Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT

被引:55
作者
Rohren, Eric M. [1 ]
Etchebehere, Elba C. [1 ,2 ]
Araujo, John C. [3 ]
Hobbs, Brian P. [4 ]
Swanston, Nancy M. [1 ]
Everding, Michael [1 ]
Moody, Tracy [1 ]
Macapinlac, Homer A. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Houston, TX 77030 USA
[2] Univ Estadual Campinas, UNICAMP, Div Nucl Med, Campinas, SP, Brazil
[3] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
关键词
fluoride PET/CT; NaF PET/CT; prostate cancer; bone metastases; skeletal tumor burden; POSITRON-EMISSION-TOMOGRAPHY; PLANAR BONE-SCINTIGRAPHY; TOTAL LESION GLYCOLYSIS; PROSTATE-CANCER; F-18-FDG PET/CT; PROGNOSTIC VALUE; F-18-SODIUM FLUORIDE; RESPONSE ASSESSMENT; HODGKINS-LYMPHOMA; CELL;
D O I
10.2967/jnumed.115.156026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of this study was to define a method to assess skeletal tumor burden with F-18-labeled sodium fluoride PET/CT (F-18-fluoride PET/CT) and evaluate the reproducibility of these measurements. Methods: Ninety-eight consecutive patients (90 men; mean age +/- SD, 65.7 +/- 14.2 y) underwent 158 F-18-fluoride PET/CT scans for evaluation of skeletal metastatic disease. In order to determine the mean normal bone SUV, initially a 1-cm spheric volume of interest (V01) was placed over 5 bone sites: T12, L5, sacrum, right iliac bone, and right femur. For each patient, the mean SUVmax, for all sites was generated. Afterward, a threshold value of normal bone uptake was established. Subsequently, skeletal tumor burden was determined by generating volumetric data using a whole-body segmentation method. Any SUVmax below the normal threshold was excluded from analysis, as were VOls not related to metastatic disease. Statistics for the remaining VOls were then generated and defined as the skeletal metastatic tumor burden by 2 parameters: total lesion fluoride uptake above an SUVmax of 10 (TLF10) and fluoride tumor volume above an SUVmax of 10 (FTV10). TLF10 and FIV10 reproducibility was determined using 2 independent and experienced PET/CT interpreters analyzing a subset of 13 F-18-fluoride PET/CT scans. Results: Mean (+/- SD) normal. bone SUVmax was 6.62 +/- 1.55 for T12, 6.11 +/- 1.73 for L5, 4.59 +/- 1.74 for sacrum, 5.39 +/- 1.72 for right iliac bone, and 3.90 +/- 1.57 for right femur. The mean normal SUVmax for all 543 sites was 5.32 +/- 0.99. On the basis of these values, an SUVmax threshold of 10 was chosen to exclude normal bone from the volumetric calculations. Semiautomated measurements of TLF10 and FTV10 exhibited high interobserver reproducibility, within +/- 0.77% and +/- 3.62% of the interinterpreter average for TLF10 and FTV10, respectively. Conclusion: Determination of skeletal tumor burden with F-18-fluoride PET/CT is feasible and highly reproducible. Using an SUVmax threshold of 10 excludes nearly all normal bone activity from volumetric calculations.
引用
收藏
页码:1507 / 1512
页数:6
相关论文
共 35 条
[1]   18F-FDG PET/CT Has a High Impact on Patient Management and Provides Powerful Prognostic Stratification in the Primary Staging of Esophageal Cancer: A Prospective Study with Mature Survival Data [J].
Barber, Thomas W. ;
Duong, Cuong P. ;
Leong, Trevor ;
Bressel, Mathias ;
Drummond, Elizabeth G. ;
Hicks, Rodney J. .
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) :864-871
[2]   Current Evidence Base of FDG-PET/CT Imaging in the Clinical Management of Malignant Pleural Mesothelioma: Emerging Significance of Image Segmentation and Global Disease Assessment [J].
Basu, Sandip ;
Saboury, Babak ;
Torigian, Drew A. ;
Alavi, Abass .
MOLECULAR IMAGING AND BIOLOGY, 2011, 13 (05) :801-811
[3]   Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate [J].
Blake, GM ;
Park-Holohan, SJ ;
Cook, GJR ;
Fogelman, I .
SEMINARS IN NUCLEAR MEDICINE, 2001, 31 (01) :28-49
[4]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[5]   18F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy [J].
Bortot, Daniel C. ;
Amorim, Barbara J. ;
Oki, Glaucia C. ;
Gapski, Sergio B. ;
Santos, Allan O. ;
Lima, Mariana C. L. ;
Etchebehere, Elba C. S. C. ;
Barboza, Marycel F. ;
Mengatti, Jair ;
Ramos, Celso Dario .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (11) :1730-1736
[6]   18F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy [J].
Carkaci, Selin ;
Sherman, Christopher T. ;
Ozkan, Efe ;
Adrada, Beatriz E. ;
Wei, Wei ;
Rohren, Eric M. ;
Mawlawi, Osama R. ;
Ueno, Naoto T. ;
Buchholz, Thomas A. ;
Yang, Wei T. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (12) :1809-1816
[7]   Prognostic Value of Whole-Body Total Lesion Glycolysis at Pretreatment FDG PET/CT in Non-Small Cell Lung Cancer [J].
Chen, Helen H. W. ;
Chiu, Nan-Tsing ;
Su, Wu-Chou ;
Guo, How-Ran ;
Lee, Bi-Fang .
RADIOLOGY, 2012, 264 (02) :559-566
[8]   18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin) [J].
Cook, Gary J. R. ;
Parker, Chris ;
Chua, Sue ;
Johnson, Bernadette ;
Aksnes, Anne-Kirsti ;
Lewington, Val J. .
EJNMMI RESEARCH, 2011, 1 :1-6
[9]  
Even-Sapir E, 2006, J NUCL MED, V47, P287
[10]   Prognostic Stratification of Metastatic Gastroenteropancreatic Neuroendocrine Neoplasms by 18F-FDG PET: Feasibility of a Metabolic Grading System [J].
Ezziddin, Samer ;
Adler, Linda ;
Sabet, Amir ;
Poeppel, Thorsten Dirk ;
Grabellus, Florian ;
Yuece, Ali ;
Fischer, Hans-Peter ;
Simon, Birgit ;
Hoeller, Tobias ;
Biersack, Hans-Juergen ;
Nagarajah, James .
JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (08) :1260-1266